Precautions six days after sudden discontinuation of selinesol/silvio
If patients with multiple myeloma suddenly stop taking Selinexor, especially after six days of use, special attention must be paid to the following changes and follow-up measures to reduce negative effects on the patient's health:
1. Monitor the progress of the disease
After discontinuation of selinesol, the patient's condition may change, especially recurrence or worsening of the tumor. Therefore, patients must be closely monitored for disease progression in the days and weeks after discontinuation of the drug. This includes regular blood tests, imaging studies, and assessment of changes in tumor-related symptoms.
2. Risk of worsening symptoms
After stopping the drug, patients may experience worsening of symptoms. For patients with multiple myeloma and diffuse largeB-cell lymphoma, worsening symptoms may manifest as fatigue, anemia, bleeding tendencies, bone pain, etc. Therefore, after stopping the drug, patients need to report any discomfort at any time and maintain close contact with their doctor.
3. Re-evaluation of treatment plans
After discontinuing selinesol, doctors may adjust the treatment plan based on the patient's specific condition. Depending on the patient's condition, a decision may be made to restart treatment with selinesol or to switch to another treatment. If the condition relapses, stronger medical intervention may be needed.
4. Managing the persistence of side effects
The side effects of selinesol may continue for some time after you stop taking the drug. For example, patients may still experience symptoms such as gastrointestinal discomfort, fatigue, or a decrease in white blood cells. Symptomatic treatment with medications or other supportive therapies is needed to help patients relieve these discomforts.
5. Pay attention to infection and immune monitoring
One of the side effects of selinesol is a suppressed immune system, making patients susceptible to infections. Even after stopping the medication, it may take some time for the patient's immune system to recover, so special attention needs to be paid to preventing infection and avoiding the invasion of external germs.
Keyword tags: selinesol, discontinuation precautions, disease progression, treatment options, side effects, immune monitoring, infection prevention, drug therapy adjustment
Reference materials:https://www.drugs.com/history/xpovio.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)